Moderna, Revolve, Fossil and more

Here’s a look at the companies that are making headlines in the after-hours business.

Moderna – The biotechnology title rose 2% after Moderna said it had enough cases of Covid-19 in its candidate vaccine trial to review the data, signaling that preliminary results could be released soon. The stock also rose more than 8% during normal trading hours on Wednesday.

Revolve Group – Shares of the fashion retailer fell more than 9% after the company reported a surprise year-over-year drop in net sales for the third quarter. Revolve reported net sales of $ 151 million for the three-month period, down from $ 154.2 million in the same quarter last year. The company said Covid-19 continued to hurt performance in the first weeks of the fourth quarter.

Fossil Group – The watchmaker’s shares climbed more than 30% after Fossil reported its third quarter results which included rising margins. The company said it earned 31 adjusted cents per share on $ 435.5 million in net sales in the quarter, which represented a 19% year-over-year drop in net sales. Fossil also said it had more than $ 300 million in cash and cash equivalents as of October 3.

Vroom – The online auto retailer’s inventory fell about 10% despite Vroom reporting a smaller-than-expected loss for its third quarter. Vroom said he lost 29 adjusted cents per share, down from an expected loss of 36 cents per share from analysts polled by FactSet. The company said consumer demand had returned to pre-pandemic levels, but its forecast for the fourth quarter of a loss per share was between 41 cents and 35 cents. Analysts polled by FactSet had received 35 cents.